TandemAI is an advanced technology company dedicated to lowering the barrier to entry to the most advanced tools in drug discovery. Our integrated drug discovery platform combines a proprietary suite of AI and physics-based drug discovery tools, custom-built supercomputing infrastructure, and large-scale wet lab operations to democratize access to the most advanced tools in drug discovery and elevate the experience of researchers.  

TandemAI’s collaborative teams of scientists partner with the global scientific community to dramatically improve the success rate of pre-clinical drug candidates and, ultimately, help improve the lives of patients waiting for new treatment options. The current focus of TandemAI is helping clients advance pre-clinical small molecule drug candidates. Our vision is to grow with our clients to support their discovery efforts in biologics and other large molecule therapies.